Cannell & Spears’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
Other funds holding ABT
VCM
VPM
Cannell & Spears's ABT Position: Q1 2026 in Review
Cannell & Spears reduced its Abbott (ABT) stake by 2.4% in Q1 2026, selling an estimated $1.56M and leaving 550,416 shares worth $56.5M. The position accounts for 1.11% of the portfolio, ranked #24.
Cannell & Spears first reported a position in ABT in Q3 2013 and has held it in 26 quarters since. The position peaked at $75.3M in Q3 2025. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.
- Cannell & Spears held 550,416 shares of Abbott worth $56.5M as of Q1 2026.
- Cannell & Spears sold 13,790 Abbott shares in Q1 2026, an estimated $1.56M.
- Abbott made up 1.11% of Cannell & Spears's portfolio in Q1 2026, its #24 holding.
- Cannell & Spears first reported a position in Abbott in Q3 2013 and has held it in 26 quarters since.
- Cannell & Spears's Abbott position peaked at $75.3M in Q3 2025.
- 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.
Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.